Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
株式のランク
#4270
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
株価
$2.22
最終同期: 2026-10-20
時価総額
$3.71B
変化（1日）
-0.13%
変化（1年）
-9.16%
国
CN
取引 Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
カテゴリー
Healthcare
Shijiazhuang Yiling Pharmaceutical Co., Ltd.（002603）の配当利回りの履歴
Shijiazhuang Yiling Pharmaceutical Co., Ltd.（銘柄コード: 002603）の配当利回り（TTM）は2023-12-31時点で2.17%です。
過去5年間の平均配当利回り: 1.71%
過去5年間の平均配当利回り: 1.71%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.（002603）の2008から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 5.32% | 280.00% |
| 2024 | 1.40% | -35.48% |
| 2023 | 2.17% | 287.50% |
| 2022 | 0.56% | -84.62% |
| 2021 | 3.64% | 366.67% |
| 2020 | 0.78% | -3.70% |
| 2019 | 0.81% | -20.59% |
| 2018 | 1.02% | 72.88% |
| 2017 | 0.59% | 31.11% |
| 2016 | 0.45% | 55.17% |
| 2015 | 0.29% | -14.71% |
| 2014 | 0.34% | 9.68% |
| 2013 | 0.31% | 10.71% |
| 2012 | 0.28% | -26.32% |
| 2011 | 0.38% | 1,166.67% |
| 2010 | 0.03% | 200.00% |
| 2009 | 0.01% | -98.25% |
| 2008 | 0.57% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 1.57% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
